CClinicalTrials.gg
CompletedNCT04837326Updated Apr 14, 2021

Effect of Using White Noise, Embracing and Facilitated Tucking in Newborns

An interventional study of Heel Lance Blood Sampling in Facilitated Tucking Position and Heel Lance Blood Sampling When the Infant is Embraced by the Mother in Pain, sponsored by T.C. ORDU ÜNİVERSİTESİ. Completed. Open to participants aged 1 Day to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-14.

Sponsored by T.C. ORDU ÜNİVERSİTESİ · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 4 years 11 months after the study started (first participant enrolled May 2016, registered Apr 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
1 Day to 28 Days
Sex
All
01

Study summary

This study was conducted to evaluate the effect of using white noise, embracing and facilitated tucking on physiological parameters, crying duration and pain during heel lance blood sampling in healthy newborns.

This study was a prospective, randomized controlled trial. The study was conducted with healthy newborns who were born between 38 and 42 weeks of gestation. The newborns were divided into 4 groups by the applied pain relief methods during heel lance blood sampling in newborns; embracing(n=40), white noise(n=40), facilitated tucking(n=40) and control group (n=40). The physiological changes were evaluated before and after the procedure. NIPS (Neonatal Infant Pain Scale) was used for pain scoring.

Read the detailed description

This study aimed to investigate the effect of white noise, embracing and facilitated tucking on pain during heel lance blood sampling in newborns.

METHODS This randomized-controlled experimental study was performed to evaluate the effect of white noise, embracing and facilitated tucking on pain during heel lance blood sampling in newborns.

Setting and sample:

The study sample consisted of healthy newborns who were born and monitored in the Neonatology Unit of a university hospital. The sample inclusion criteria were gestational age between 38 and 42 weeks, birth weight of 2500 - 4000 g, Apgar score of 8 and higher at 1st and 5th minute, having breastfed at least half an hour before the procedure, not showing any disease symptom, not having congenital anomaly, getting a good hearing test result and not having received any invasive intervention other than Vitamin K and Hepatitis B vaccine.

Sample size:

Following previous studies, G*Power (v3.1.9.2) was deployed to determine the sample number. According to Jacob Cohen's effect size coefficients, assuming that evaluations carried out among four independent groups would have a large effect size (d=0.40), it was determined that the groups should comprise least 40 people, with a total of 160, for levels of α=0.05 and 1-β=0.95 (80% power). Children were assigned to 4 subgroups through randomization performed using a computer program (www.randomizer.org): group 1 was the control group children who received no intervention for pain relief (n = 40); group 2 received facilitated tucking (n = 40); group 3 received embracing (n = 40); and group 4 received white noise (n = 40).

Intervention:

The mothers were informed by the researcher about the purpose of the study before collecting data. The infants were held by their mothers so that their faces, arms, legs and respirations could be easily viewed by the camera to evaluate the NIPS. All heel lance procedures were performed by the same nurse working on the day shift (who had 6-year NICU experience). The heel lance blood sampling point (outer side of the left heel), the lancet used in the procedure, the sampling technique, and the antiseptic solution (70% alcohol) used in for the procedure were the same for all the groups. The heel lance blood sampling procedure was performed by the researcher in the blood sampling room in the Neonatology ward. Suitable environmental conditions (ambient temperature, silent environment, etc.) were ensured in the study room for the infant's comfort. A saturation probe was inserted to the right wrist of the infant to monitor him/her. The behavioral responses to pain and crying durations of all the responses were recorded by camera before, during and after the procedure. Then, these records were played and the NIPS scores and crying durations of the infants were evaluated. The physiological changes were recorded before, during and after the procedure, respectively. In the data collection stage, 3 persons (nurse putting the infant in facilitated tucking position, nurse taking blood sample, researcher shooting video) were required for facilitated tucking position; 2 persons (nurse taking blood sample and researcher shooting video) for maternal embracing since the infant was held by the mother and 2 persons (nurse taking blood sample and researcher shooting video) for white noise.

Heel Lance Blood Sampling in Facilitated Tucking Position:

The infants were put in facilitated tucking position by an experienced newborn nurse. They were put in facilitated tucking position so that their arms and legs were in a flexed midline position close to their trunk in a side-lying position. They were positioned so that they could move their extremities freely. They were held in facilitated tucking position for 120 seconds before the procedure. They were kept in facilitated tucking position until the blood sample was taken from the right heel using a lancet. They were released 60 seconds after the procedure and monitored for 120 seconds. The blood samples were taken by the researcher after inserting the lancet in the first try.

Heel Lance Blood Sampling When the Infant is Embraced by the Mother:

The mother, whose privacy was protected, embraced the infant for 120 seconds before the procedure. The infant was embraced by the mother during the heel lance blood sampling from the left heel using a lancet. They were released 60 seconds after the procedure and monitored for 120 seconds. The blood samples were taken by the researcher after inserting the lancet in the first try.

Heel Lance Blood Sampling Using White Noise:

The 'Don't Let Your Baby Cry, PT.2' track from the 'Colic' album by Orhan Osman using the 'The Happiest Baby' album by Dr. Harvery Karp which was composed only of intrauterine was made listened to the infants via Xperia Ultra Mp3 Player for 120 seconds before and 120 seconds after the heel lance blood sampling procedure. While white noise was made listened to the infants before, during and after the procedure, Digital Sound LeverMeter brand noise measurement device was put at a distance of 50 cm from the infant and the ambient noise level was adjusted as 55 dB. The blood samples were taken by the researcher after inserting the lancet in the first try.

Control Group:

Suitable environmental conditions (ambient temperature, silent environment, etc.) were ensured in the study room for the infant's comfort. A saturation probe was inserted to the right wrist of the infant to monitor him/her. A video record was taken for 120 seconds without any intervention to the infants before and after the heel lance blood sampling procedure. The blood samples were taken by the researcher after inserting the lancet in the first try. Heel lance was performed in clinical routine for preterm infants in the control group.

02

Conditions studied

  • Pain
03

In context

Lead sponsor

T.C. ORDU ÜNİVERSİTESİ is the lead sponsor of 87 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • gestational age between 38 and 42 weeks,
  • birth weight of 2500 - 4000 g,
  • Apgar score of 8 and higher at 1st and 5th minute,
  • having breastfed at least half an hour before the procedure,
  • not showing any disease symptom,

Exclusion criteria

Exclusion Criteria:

  • having congenital anomaly,
  • getting a good hearing test result
  • having received any invasive intervention other than Vitamin K and Hepatitis B vaccine.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Heel Lance Blood Sampling in Facilitated Tucking Position

    The infants were put in facilitated tucking position by an experienced newborn nurse. They were put in facilitated tucking position so that their arms and legs were in a flexed midline position close to their trunk in a side-lying position. They were positioned so that they could move their extremities freely. They were held in facilitated tucking position for 120 seconds before the procedure. They were kept in facilitated tucking position until the blood sample was taken from the right heel using a lancet. They were released 60 seconds after the procedure and monitored for 120 seconds. The blood samples were taken by the researcher after inserting the lancet in the first try.

    Other: Heel Lance Blood Sampling in Facilitated Tucking Position

  • Experimental
    Heel Lance Blood Sampling When the Infant is Embraced by the Mother

    The mother, whose privacy was protected, embraced the infant for 120 seconds before the procedure. The infant was embraced by the mother during the heel lance blood sampling from the left heel using a lancet. They were released 60 seconds after the procedure and monitored for 120 seconds. The blood samples were taken by the researcher after inserting the lancet in the first try.

    Other: Heel Lance Blood Sampling When the Infant is Embraced by the Mother

  • Experimental
    Heel Lance Blood Sampling Using White Noise

    The 'Don't Let Your Baby Cry, PT.2' track from the 'Colic' album by Orhan Osman using the 'The Happiest Baby' album by Dr. Harvery Karp which was composed only of intrauterine was made listened to the infants via Xperia Ultra Mp3 Player for 120 seconds before and 120 seconds after the heel lance blood sampling procedure. While white noise was made listened to the infants before, during and after the procedure, Digital Sound LeverMeter brand noise measurement device was put at a distance of 50 cm from the infant and the ambient noise level was adjusted as 55 dB. The blood samples were taken by the researcher after inserting the lancet in the first try.

    Other: Heel Lance Blood Sampling Using White Noise

  • No intervention
    Control Group

    Suitable environmental conditions (ambient temperature, silent environment, etc.) were ensured in the study room for the infant's comfort. A saturation probe was inserted to the right wrist of the infant to monitor him/her. A video record was taken for 120 seconds without any intervention to the infants before and after the heel lance blood sampling procedure. The blood samples were taken by the researcher after inserting the lancet in the first try. Heel lance was performed in clinical routine for preterm infants in the control group.

Interventions

  • OtherHeel Lance Blood Sampling in Facilitated Tucking Position
  • OtherHeel Lance Blood Sampling When the Infant is Embraced by the Mother
  • OtherHeel Lance Blood Sampling Using White Noise
06

What researchers measure

Primary outcomes

  1. Neonatal Pain

    Neonatal Infant Pain Scale

    Time frame: 15 minutes

  2. Crying Duration

    Crying durations of the infants.

    Time frame: 15 minutes

  3. Physiological Parameters 1

    Pulse rate

    Time frame: 15 minutes

  4. Physiological Parameters 2

    SpO2

    Time frame: 15 minutes

  5. Physiological Parameters 3

    Respiration rate

    Time frame: 15 minutes

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Results

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 14, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04837326
Lead sponsor
T.C. ORDU ÜNİVERSİTESİ
Responsible party
Dilekkucu Kalemdar (Associate Prof. Dr, T.C. ORDU ÜNİVERSİTESİ) — Principal investigator
First posted
Apr 8, 2021
Start date
May 1, 2016
Primary completion
Dec 30, 2017
Completion
Dec 30, 2017
Last update
Apr 14, 2021

Study contacts

Yavuz ÖZORAN, Professor
study director · Avrasya University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion